AF-Summit

Wednesday, May 6 -10:00 a.m. – 5:00 p.m.

The AF Summit is a “one-stop” comprehensive update on the discoveries and advancements in AF management that have taken place over the last year and the impacts these changes have on how we manage AF patients today. Examining recent developments in science, spanning those that are widely accepted to controversial, this summit will feature state-of-the-art talks about AF ablation given by leaders in the field with dedicated time for panel discussions and Q&As, as well as debates on contestable changes impacting everyday clinical practice. The AF Summit will conclude with presentations of the most important manuscripts on AF selected by editors from the leading heart rhythm and cardiology journals. 

 

D-AF01 AF Summit I - Population Issues

Session Description: This session will explore methods for identifying atrial fibrillation in large populations and discuss the potential benefits and unintended consequences of this approach.  Population based strategies focusing on weight loss, exercise, and overall health may have a significant impact on the incidence of atrial fibrillation. Finally, data on atrial fibrillation burden and stroke risk, the association of atrial fibrillation with dementia, and novel strategies for reducing risk of stroke due to atrial fibrillation will be evaluated.  

 

D-AF02 AF Summit II - Clinical Trials

Session Description: This session will evaluate the most up to date data on ablation for atrial fibrillation.  The role of ablation in managing patients with atrial fibrillation will be discussed in light of the recent publication of the CABANA trial.  The impact of atrial fibrillation ablation on mortality, hospitalizations, arrhythmia recurrence, and quality of life will be explored.  

 

D-AF03 AF Summit III - Innovation

Session Description: This session will focus on new innovative strategies for the management of atrial fibrillation.  New mapping technology may allow individualized ablation strategies, while new ablation targets and new energy sources may provide more effective treatment of atrial fibrillation.  In addition to targeting the arrhythmia, the rapid evolution of drugs and nonpharmacologic therapies to reduce atrial fibrillation related cerebrovascular events will be addressed in this session.

 

D-AF04 AF Summit IV - Ablation in 2020, 2021, and 2022  

Session Description: This session will focus on what are the most up-to-date techniques and strategies for atrial fibrillation ablation that are currently in use and will likely be adopted over the next one to years.  The relative advantages and disadvantages of point-to-point ablation and “single -shot” ablation techniques will be discussed.  In addition to currently available or soon to be available technology, this session will discuss our current understanding of the best tissue targets and lesion sets for treatment of persistent atrial fibrillation. 

 

D-AF05 AF Summit: Continuing the Conversation   

Session Description: Format: Discussion without use of audiovisual aids with three 20 minute sessions focusing on the following topics (and others as time permits and depending on the flow of the discussion): Part 1: New Tools for Identifying AF (20 minutes) Part 2: How best to do AF ablation now (20 minutes) Part 3: How will we be doing AF ablation in the future? (20 minutes)

Exit Heart Rhythm Scientific Sessions

You are about to exit the Heart Rhythm Scientific Sessions website. Upon clicking the Continue button, you will be redirected to an external website.

Loading...

Continue